|
MEDICAL SPECIALITIES >
Diabetes |
|
The classical
treatments used until now for
the control of diabetes have
been oral anti-diabetics and
human insulin. The problem of
the oral anti-diabetics is the
great number of hypoglycaemias
(lowering of blood sugar) which
they produce. Also in the long
term they worsen the prognosis
because they over-stimulate the
pancreas and made the diabetic
dependent on insulin at an
earlier age.
Human insulin
used to produce a large number
of allergic reactions, and at
times the patients did not
tolerate it. As a consequence
they sometimes stopped its use,
thus resulting in the death of
the patient, as a direct
consequence of the lack of
control of the glucose in the
blood.
In the Hilu
Medical Centre we are going to
use a new range of oral
anti-diabetics which NEVER
produce hypoglycaemia, and which
make it possible to avoid the
use of insulin up to very
advanced age and, in some cases,
help to withdraw the insulin
from patients who had been using
it for some time.
Some of these
compounds, in particular those
called ‘inhibitors of the GLP-1
enzyme’, are also used in the
United States to lose weight,
due to the slowing down of the
emptying of the stomach which
they produce, giving an early
sensation of fullness, and also
because of the slight metabolic
increase which they induce.
In CMH our
specialist, Dr. Martinez
Peñalver, has participated in
the development of these
products as a researcher, and at
present is the doctor who uses
them most in the community of
Andalusia, being therefore, very
expert in their handling.
The new
insulin, obtained by recombinant
DNA technology, makes it
possible to stop using the
previous type of insulin, its
only side-effect being
hypoglycaemia in the case of an
overdose. Basically there are
several types of the ‘new
insulin’: fast acting, which
acts from 15 minutes to 3-4
hours after the injection, and
the slow acting, which disperses
in the body gradually over 24
hours.
The objective
of the present diabetologist is
to rescue the patient already
using insulin, and replace it
with the treatments just
mentioned and, if the use of
insulin is necessary, to
organise the doses following a
comfortable scheme which will
not interfere with the patient’s
lifestyle, but will protect him
from the secondary complications
of the illness.
Do not
hesitate; request an appointment
with our Doctor who specialises
in Internal Medicine, and who
will provide more information.
|